Loading...

Long-term safety of aromatase inhibitors in the treatment of breast cancer

Following promising data for metastatic breast cancer in terms of efficacy and safety profile, third-generation aromatase inhibitors (AI), anastrozole, letrozole, and exemestane, underwent a full development in early setting. If recent results consistently show the superiority of these agents over t...

Full description

Saved in:
Bibliographic Details
Main Author: Nabholtz, Jean-Marc A
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2008
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2503653/
https://ncbi.nlm.nih.gov/pubmed/18728707
Tags: Add Tag
No Tags, Be the first to tag this record!